Salim Y. Inan
Meram, 42080, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting the Rho/ROCK Signaling Pathway Mitigates Mitochondrial Dysfunction in 6-OHDA-Induced Models of Parkinson's Disease, Both In Vivo and In Vitro.
Journal: Molecular neurobiology
Published: May 14, 2025
P/Q type (Cav2.1) Calcium Channel Blocker ω-Agatoxin IVA Alters Cleaved Caspase-3 and BDNF Expressions in the Rat Brain and Suppresses Seizure Activity.
Journal: Molecular neurobiology
Published: August 15, 2023
The Sirtuin 2 Inhibitor AK-7 Leads to an Antidepressant-Like Effect in Mice via Upregulation of CREB1, BDNF, and NTRK2 Pathways.
Journal: Molecular neurobiology
Published: May 26, 2022
Neuroprotective Effect of Intrastriatal Caffeic Acid Phenethyl Ester Treatment in 6-OH Dopamine Model of Parkinson's Disease in Rats.
Journal: Parkinson's disease
Published: February 07, 2021
Erratum to: Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
Journal: Metabolic brain disease
Published: May 29, 2016
Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
Journal: Metabolic brain disease
Published: December 04, 2015
Epileptogenic effects of G protein-coupled estrogen receptor 1 in the rat pentylenetetrazole kindling model of epilepsy.
Journal: Pharmacological reports : PR
Published: April 06, 2015
Infralimbic cortex Rho-kinase inhibition causes antidepressant-like activity in rats.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: August 14, 2014
Influence of sex on the interaction between dizocilpine (MK-801) pretreatment and acute cold-restraint stress in epilepsy susceptibility in an animal study.
Journal: Gender medicine
Published: December 20, 2007
Showing 1-9 of 9
Last Updated: 09/26/2026